This website is no longer updated

The Swiss National COVID-19 Science Task Force was dissolved on 31 March 2022.

It has been replaced by the Scientific Advisory Panel to ensure that the cantons and the Confederation can continue to benefit from scientific expertise in the context of the SARS-CoV-2 pandemic.

This website is therefore no longer updated, but its content remains accessible as an archive.

3 May 2020 – Compilation and review

Vaccines and Treatments for Sars-CoV-2/COVID-19

Download Policy Brief PDF

English

This document lists ongoing studies on vaccines and treatment of COVID-19 in Switzerland and beyond.

Date of request: –
Date of response: 3/5/2020

In response to request from: –

Comment on planned updates: Update planned as soon as an important body of new evidence becomes available.

Expert groups and individuals involved: Pascale Vonaesch (Swiss TPH) and Marcel Tanner (a+ / SwissTPH); with assistance from Manuel Battegay and Oriol Manuel (University Hospital Basel)

Contact persons: –

Sources used/searched: WHO COVID-19 pages, ClinicalTrial.gov, www.clinicaltrialsregister.eu, www.kofam.ch, Coronavirus Treatment tracker by Damian Garde, SwissEthics, PubMed, BioRvix and MedRvix selected search for neutralizing antibodies and screens for new antiviral drugs and news articles regarding research in Switzerland (especially University press releases).

This website is no longer updated

The Swiss National COVID-19 Science Task Force was dissolved on 31 March 2022.

It has been replaced by the Scientific Advisory Panel to ensure that the cantons and the Confederation can continue to benefit from scientific expertise in the context of the SARS-CoV-2 pandemic.

This website is therefore no longer updated, but its content remains accessible as an archive.

Continue on the website of the Scientific Advisory Panel COVID-19
Continue on this website